S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
66,000% upside on tiny biotech? (Ad)
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
CrowdStrike: Another Tech Stock to Buy on the Dip 
66,000% upside on tiny biotech? (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
66,000% upside on tiny biotech? (Ad)
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
CrowdStrike: Another Tech Stock to Buy on the Dip 
66,000% upside on tiny biotech? (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
66,000% upside on tiny biotech? (Ad)
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
CrowdStrike: Another Tech Stock to Buy on the Dip 
66,000% upside on tiny biotech? (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
66,000% upside on tiny biotech? (Ad)
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
CrowdStrike: Another Tech Stock to Buy on the Dip 
66,000% upside on tiny biotech? (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NASDAQ:AFIB

Acutus Medical (AFIB) Price Target & Analyst Ratings

$0.85
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.79
$0.86
50-Day Range
$0.66
$1.02
52-Week Range
$0.48
$2.15
Volume
62,488 shs
Average Volume
156,268 shs
Market Capitalization
$24.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Acutus Medical Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$2.00
136.41% Upside
High Prediction$2.50
Average Prediction$2.00
Low Prediction$1.50
TypeCurrent
6/3/22 to 6/3/23
1 Month Ago
5/4/22 to 5/4/23
3 Months Ago
3/5/22 to 3/5/23
1 Year Ago
6/3/21 to 6/3/22
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$2.00$2.00$2.00$7.00
Predicted Upside136.41% Upside63.27% Upside63.27% Upside33.49% Upside
Get Acutus Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.


AFIB Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AFIB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Acutus Medical Stock vs. The Competition

TypeAcutus MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.66
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside136.41% Upside1,266.34% Upside199.96% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/16/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$1.50+3.45%
8/15/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$2.50+72.41%
(Data available from 6/3/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AFIB Price Target - Frequently Asked Questions

What is Acutus Medical's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Acutus Medical stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for AFIB. The average twelve-month price prediction for Acutus Medical is $2.00 with a high price target of $2.50 and a low price target of $1.50. Learn more on AFIB's analyst rating history.

Do Wall Street analysts like Acutus Medical more than its competitors?

Analysts like Acutus Medical less than other Medical companies. The consensus rating for Acutus Medical is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how AFIB compares to other companies.

Does Acutus Medical's stock price have much upside?

According to analysts, Acutus Medical's stock has a predicted upside of 63.27% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:AFIB) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -